Navigation Links
FDA Approves Hi-Flex Mobile Bearing Knee for Active Adults
Date:1/3/2008

Dr. Mitchell Sheinkop first to perform implant in February

CHICAGO, Jan. 2 /PRNewswire/ -- Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago. Last week, the FDA approved the Zimmer Holdings knee, which is heralded as the next generation of knee prostheses for active adults, especially amateur and professional athletes. Dr. Sheinkop was one of eight physician investigators in the United States who participated in the clinical trial proceeding FDA approval.

The main difference between a fixed bearing, or traditional knee replacement, and a mobile bearing knee is that the articulating surface is free to rotate slightly along with the patient's natural movement.

"The design of this knee allows for better range of motion and improved flexibility for daily activities, whether around the home, at work or during sports and exercise," says Dr. Sheinkop, an orthopedic surgeon and Director of Joint Replacement at the NOHC. "The knee is designed for patients who want high-flexion and have demanding lifestyles/habits. If you want to do deep knee bends, this is the knee you should choose."

Just ask athlete and lawyer Charles Zarzecki, who has a work hard, play hard mentality. Zarzecki, age 50, participated in the clinical trial for the Next Gen LPS-Flex mobile bearing knee and now plays in a Chicago-based USA Hockey team that placed 2nd in the 2007 National Pond Hockey Championships.

"In 2004, I was playing competitive basketball and there was little cartilage left in my knee," says Zarzecki. "After four arthroscopic surgeries, my leg still bowed out, and I knew it was time to do something if I wanted to continue my active lifestyle." Besides hockey, Zarzecki's knee allows him to participate in golfing, biking, spinning and snow skiing.

In 2001, Dr. Sheinkop was first exposed to the mobile bearing knee through an invitation from the Ministry of Health for the United Arab Emirates. At that time he recognized the impact a high performance prosthesis could have to his athletic patients back at home.

The Neurologic & Orthopedic Hospital of Chicago is the country's first freestanding acute care hospital dedicated exclusively to neuroscience and orthopedic services. It utilizes breakthrough technology and minimally invasive techniques as well as advanced procedures for neurosurgery, orthopedics, pain management, neuro-oncology, sports medicine, and rehabilitation.

For more information on mobile bearing knee replacement at the NOHC, call: 773-250-1000 or visit http://www.neuro-ortho.org.


'/>"/>
SOURCE The Neurologic & Orthopedic Hospital of Chicago
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... , ... IndustryArchive.Org . is announcing a new way for B2B Sellers ... only pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase ... reality that B2B buyers are controlling the sales process via the Internet and that ...
(Date:2/26/2017)... ... ... ODH, Inc.™ announced today it will exhibit and speak at the 10th ... Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present on how ... management. , ODH will also have an exhibit booth where attendees may speak to ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide ... with a specific LRRK2 mutation, according to a study released today at the ... evidence of a link between pesticides and incidence of sporadic PD through occupational ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, ... Go. Core benefits and advantages built into the home office sit stand solution ... and feel. Ability to gain the benefits embedded in the TaskMate Go are ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official release ... show in Cannes (France), XO Private has initiated a second print-run of its lavish ... almost a metre across when open, weighs in at more than six kilos, retails ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... DUBLIN , Feb. 24, 2017 Research ... Health Market Analysis & Trends - Industry Forecast to 2025" ... ... at a CAGR of around 23.8% over the next decade to ... analyzes the market estimates and forecasts for all the given segments ...
(Date:2/24/2017)... Research and Markets has announced the addition of ... to 2025" report to their offering. ... The Global Empty Capsules Market is poised to grow ... approximately $2.9 billion by 2025. This industry report analyzes ... as well as regional levels presented in the research scope. The study ...
(Date:2/24/2017)... Research and Markets has announced the addition of the "Dry ... offering. ... Dry eye Drugs Price Analysis and Strategies - 2016, provides drug pricing ... answers the following questions: What are the ... they positioned in the Global Dry eye market? What ...
Breaking Medicine Technology: